In vitro susceptibility of Clostridium difficile isolates to cefotaxime, moxalactam, and cefoperazone.
The in vitro susceptibility of 20 isolates of Clostridium difficile to cefotaxime, moxalactam, and cefoperazone was determined by a standard agar dilution method. The median minimal inhibitory concentrations were 64, 32, and 32 mug/ml for cefotaxime, moxalactam, and cefoperazone, respectively.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002438:Cefoperazone; D002439:Cefotaxime / Q000494:pharmacology; D002511:Cephalosporins / Q000494:pharmacology; D002513:Cephamycins / Q000494:pharmacology; D003013:Clostridium / Q000187:drug effects*; D008826:Microbial Sensitivity Tests; D009070:Moxalactam
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D002513:Cephamycins; D002438:Cefoperazone; D002439:Cefotaxime; D009070:Moxalactam